Reported Sep 8, 2021 · Terminated
Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A,…
Granules USA, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Granules USA, Inc. · 35 Waterview Blvd Fl 3 · Parsippany, NJ · 07054-1200
Is this the product you have?
- Naproxen Sodum Tablets USP 220 mg, (Caplet)
- Manufactured by
Granules India LimitedSy.No. 160/A161/E162&174/AGagillapur VillageDundigal-Gandimalsamma MondayMedchai-Maikhajgir District - 500043TelanganaINDIA. NDC 62207-762-36
- Lot codes and dates
- 7620060a
- Amount recalled
- 11,450,000 tablets
Where it was sold
Why it was recalled
CGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Granules USA, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.